133 related articles for article (PubMed ID: 31317822)
1. Therapeutic effect of yttrium oxide nanoparticles for the treatment of fulminant hepatic failure.
Song X; Shang P; Sun Z; Lu M; You G; Yan S; Chen G; Zhou H
Nanomedicine (Lond); 2019 Oct; 14(19):2519-2533. PubMed ID: 31317822
[No Abstract] [Full Text] [Related]
2. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
3. Multi-organ Toxicity Attenuation by Cerium Oxide and Yttrium Oxide Nanoparticles: Comparing the Beneficial Effects on Tissues Oxidative Damage Induced by Sub-acute Exposure to Diazinon.
Navaei-Nigjeh M; Daniali M; Rahimifard M; Khaksar MR
Pharm Nanotechnol; 2020; 8(3):225-238. PubMed ID: 32767961
[TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.
Dong L; Yin L; Quan H; Chu Y; Lu J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057809
[TBL] [Abstract][Full Text] [Related]
5. Cerium and yttrium oxide nanoparticles against lead-induced oxidative stress and apoptosis in rat hippocampus.
Hosseini A; Sharifi AM; Abdollahi M; Najafi R; Baeeri M; Rayegan S; Cheshmehnour J; Hassani S; Bayrami Z; Safa M
Biol Trace Elem Res; 2015 Mar; 164(1):80-9. PubMed ID: 25516117
[TBL] [Abstract][Full Text] [Related]
6. Neuro-protective effects of cerium and yttrium oxide nanoparticles on high glucose-induced oxidative stress and apoptosis in undifferentiated PC12 cells.
Ghaznavi H; Najafi R; Mehrzadi S; Hosseini A; Tekyemaroof N; Shakeri-Zadeh A; Rezayat M; Sharifi AM
Neurol Res; 2015 Jul; 37(7):624-32. PubMed ID: 25786672
[TBL] [Abstract][Full Text] [Related]
7. CQMUH-011, a novel adamantane sulfonamide compound, inhibits lipopolysaccharide- and D-galactosamine-induced fulminant hepatic failure in mice.
Yan L; Hu X; Wu Q; Jiang R; Zhang S; Ling Q; Liu H; Jiang X; Wan J; Liu Y
Int Immunopharmacol; 2017 Jun; 47():231-243. PubMed ID: 28433945
[TBL] [Abstract][Full Text] [Related]
8. The antagonistic effect of tamoxifen against d-galactosamine/lipopolysaccharide-induced acute liver failure is associated with reactivation of hepatic nuclear factor-κB.
Liu L; Zhao Y; Lin Y; Zhang R; Luo S; Ye P; Luo M
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):192-198. PubMed ID: 30721100
[No Abstract] [Full Text] [Related]
9. Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice.
Ben-Ari Z; Zilbermints V; Pappo O; Avlas O; Sharon E; Greif F; Cheporko Y; Ravid A; Shapiro R; Hochhauser E
Transplantation; 2011 Jul; 92(1):18-24. PubMed ID: 21516061
[TBL] [Abstract][Full Text] [Related]
10. Obeticholic acid differentially regulates hepatic injury and inflammation at different stages of D-galactosamine/lipopolysaccharide-evoked acute liver failure.
Ding W; Fan YY; Zhang C; Fu L; Chen X; Xu DX
Eur J Pharmacol; 2019 May; 850():150-157. PubMed ID: 30772394
[TBL] [Abstract][Full Text] [Related]
11. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Wu YL; Lian LH; Jiang YZ; Nan JX
J Pharm Pharmacol; 2009 Oct; 61(10):1375-82. PubMed ID: 19814871
[TBL] [Abstract][Full Text] [Related]
13. Lycopene Prevents Mitochondrial Dysfunction during d-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats.
Sheriff SA; Shaik Ibrahim S; Devaki T; Chakraborty S; Agarwal S; Pérez-Sánchez H
J Proteome Res; 2017 Sep; 16(9):3190-3199. PubMed ID: 28758404
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of cerium oxide and yttrium oxide nanoparticles on reduction of oxidative stress induced by sub-acute exposure to diazinon in the rat pancreas.
Khaksar MR; Rahimifard M; Baeeri M; Maqbool F; Navaei-Nigjeh M; Hassani S; Moeini-Nodeh S; Kebriaeezadeh A; Abdollahi M
J Trace Elem Med Biol; 2017 May; 41():79-90. PubMed ID: 28347467
[TBL] [Abstract][Full Text] [Related]
16. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.
Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X
Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915
[TBL] [Abstract][Full Text] [Related]
17. Hepatoprotective effects and structure-activity relationship of five flavonoids against lipopolysaccharide/d-galactosamine induced acute liver failure in mice.
He Y; Xia Z; Yu D; Wang J; Jin L; Huang D; Ye X; Li X; Zhang B
Int Immunopharmacol; 2019 Mar; 68():171-178. PubMed ID: 30641432
[TBL] [Abstract][Full Text] [Related]
18. Emodin ameliorated lipopolysaccharide-induced fulminant hepatic failure by blockade of TLR4/MD2 complex expression in D-galactosamine-sensitized mice.
Yin X; Gong X; Jiang R; Kuang G; Wang B; Zhang L; Xu G; Wan J
Int Immunopharmacol; 2014 Nov; 23(1):66-72. PubMed ID: 25173984
[TBL] [Abstract][Full Text] [Related]
19. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
Li Y; Wang N; Jiang Y
Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
[TBL] [Abstract][Full Text] [Related]
20. Cerium and Yttrium Oxide Nanoparticles and Nano-selenium Produce Protective Effects Against H2O2-induced Oxidative Stress in Pancreatic Beta Cells by Modulating Mitochondrial Dysfunction.
Tavoosi S; Baghsheikhi AH; Shetab-Boushehri SV; Navaei-Nigjeh M; Sarvestani NN; Karimi MY; Ranjbar A; Ebadollahi-Natanzi A; Hosseini A
Pharm Nanotechnol; 2020; 8(1):63-75. PubMed ID: 31577213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
